Sophiris Bio, Inc.
SPHS
SPHS was delisted on the 11th of March, 2020.
29 hedge funds and large institutions have $5.76M invested in Sophiris Bio, Inc. in 2016 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 6 closing their positions.
167% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 6
125% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 4
74% more capital invested
Capital invested by funds: $3.31M → $5.76M (+$2.45M)
53% more funds holding
Funds holding: 19 → 29 (+10)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$2.85M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$444K |
| 3 |
Millennium Management
New York
|
+$130K |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$121K |
| 5 |
AL
Airain Ltd
St. Peter Port,
Guernsey
|
+$119K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$1.05M |
| 2 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$929K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$106K |
| 4 |
Jane Street
New York
|
-$58K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$45K |
SPHS Hedge Fund Activity: Q3 2016 in Review
29 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Sophiris Bio, Inc. (SPHS) for Q3 2016, worth a combined $5.76M — up 74% from $3.31M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new SPHS positions and 6 closed out — a net gain of 10 holders — while 9 added to existing stakes and 4 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $2.85M. The largest seller was Rock Springs Capital Management, exiting entirely with an estimated $1.05M sold.
- 29 institutional investors held Sophiris Bio, Inc. (SPHS) as of Q3 2016, up from 19 in Q2 2016.
- Funds reported $5.76M of Sophiris Bio, Inc. stock for Q3 2016, up 74% quarter-over-quarter.
- 16 funds opened new Sophiris Bio, Inc. positions in Q3 2016 and 6 closed out, a net change of +10 holders.
- The largest Sophiris Bio, Inc. buyer in Q3 2016 was Sabby Management, an estimated $2.85M added.
- The largest Sophiris Bio, Inc. seller in Q3 2016 was Rock Springs Capital Management, an estimated $1.05M sold.
Based on aggregated 13F filings for Q3 2016.